02/22/2026
Big news from our residency program.
Columbia Neurosurgery PGY-4 Arjun Adapa, MD has been named a 2026 Trainee Associate Membership Program Postdoctoral Pilot Award recipient by the Herbert Irving Comprehensive Cancer Center.
His project, “Engineered Probiotic Bacteria for Therapeutic Immune Modulation in Glioblastoma,” explores a bold new strategy for one of the most aggressive brain tumors.
By using engineered probiotic bacteria to influence the tumor’s immune environment, this work aims to expand possibilities for combination therapies and improve outcomes for patients facing Glioblastoma.
The award supports early-stage, high-impact cancer research led by trainees and helps accelerate translational discoveries across Columbia’s cancer research community.
As part of the program, Dr. Adapa will present his research through Columbia cancer forums and contribute to the HICCC trainee community through mentorship and peer review.
Congratulations to Dr. Adapa on this well-deserved recognition and on pushing the boundaries of brain tumor research.